Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use.

Authors

• Charles Y Huang
• Saloni A Shah
• Mikayla Cochrane
• Annyella Douglas
• Sherry Yang

Publication/Presentation Date

3-21-2024

Abstract

Hidradenitis suppurativa (HS) is a painful chronic skin condition of apocrine gland regions. This retrospective cohort study aimed to assess the impact of hormonal contraception type on HS disease control in adult women. In total, 160 patients were included, with the majority identifying as Black or African American (73.1%). Multivariate logistic regression showed that oestrogen-progesterone users were 3.14 times more likely to experience stable or improved HS than progesterone-only users (adjusted odds ratio 3.14, 95% CI 1.18-8.35; P = 0.02). Further investigation is needed to elucidate the antiandrogenic mechanisms affecting HS symptom response to hormonal contraceptives.

Volume

49

Issue

4

First Page

375

Last Page

378

ISSN

1365-2230

Published In/Presented At

Huang, C. Y., Shah, S. A., Cochrane, M., Douglas, A., & Yang, S. (2024). Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use. Clinical and experimental dermatology, 49(4), 375–378. https://doi.org/10.1093/ced/llad385

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

37940109

Department(s)

Administration and Leadership

Document Type

Article